View in EDS HTML Full Text PDF Full Text

Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.

Saved in:
Bibliographic Details
Title: Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
Authors: Lykins WR; Access to Advanced Health Institute, Seattle, WA, United States., Pollet J; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., White JA; PATH, Seattle, WA, United States., Keegan B; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Versteeg L; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Strych U; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Chen WH; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Mohamath R; Access to Advanced Health Institute, Seattle, WA, United States., Ramer-Denisoff G; Access to Advanced Health Institute, Seattle, WA, United States., Reed S; Access to Advanced Health Institute, Seattle, WA, United States., Renshaw C; Access to Advanced Health Institute, Seattle, WA, United States., Beaver S; Access to Advanced Health Institute, Seattle, WA, United States., Gerhardt A; Access to Advanced Health Institute, Seattle, WA, United States., Voigt EA; Access to Advanced Health Institute, Seattle, WA, United States., Tomai MA; 3M Health Care, St. Paul, MN, United States., Sitrin R; PATH, Seattle, WA, United States., Choy RKM; PATH, Seattle, WA, United States., Cassels FJ; PATH, Seattle, WA, United States., Hotez PJ; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Department of Biology, Baylor University, Waco, TX, United States., Bottazzi ME; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States., Fox CB; Access to Advanced Health Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
Source: Frontiers in immunology [Front Immunol] 2024 Dec 16; Vol. 15, pp. 1480976. Date of Electronic Publication: 2024 Dec 16 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39737197
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lykins+WR%22">Lykins WR</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Pollet+J%22">Pollet J</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22White+JA%22">White JA</searchLink>; PATH, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Keegan+B%22">Keegan B</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Versteeg+L%22">Versteeg L</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Strych+U%22">Strych U</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Chen+WH%22">Chen WH</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Mohamath+R%22">Mohamath R</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Ramer-Denisoff+G%22">Ramer-Denisoff G</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Reed+S%22">Reed S</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Renshaw+C%22">Renshaw C</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Beaver+S%22">Beaver S</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Gerhardt+A%22">Gerhardt A</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Voigt+EA%22">Voigt EA</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Tomai+MA%22">Tomai MA</searchLink>; 3M Health Care, St. Paul, MN, United States.<br /><searchLink fieldCode="AU" term="%22Sitrin+R%22">Sitrin R</searchLink>; PATH, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Choy+RKM%22">Choy RKM</searchLink>; PATH, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Cassels+FJ%22">Cassels FJ</searchLink>; PATH, Seattle, WA, United States.<br /><searchLink fieldCode="AU" term="%22Hotez+PJ%22">Hotez PJ</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.; Department of Biology, Baylor University, Waco, TX, United States.<br /><searchLink fieldCode="AU" term="%22Bottazzi+ME%22">Bottazzi ME</searchLink>; Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine, Houston, TX, United States.; Department of Pediatrics, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX, United States.<br /><searchLink fieldCode="AU" term="%22Fox+CB%22">Fox CB</searchLink>; Access to Advanced Health Institute, Seattle, WA, United States.; Department of Global Health, University of Washington, Seattle, WA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2024 Dec 16; Vol. 15, pp. 1480976. <i>Date of Electronic Publication: </i>2024 Dec 16 (<i>Print Publication: </i>2024).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39737197
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2024.1480976
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1480976
    Titles:
      – TitleFull: Optimizing immunogenicity and product presentation of a SARS-CoV-2 subunit vaccine composition: effects of delivery route, heterologous regimens with self-amplifying RNA vaccines, and lyophilization.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lykins WR
      – PersonEntity:
          Name:
            NameFull: Pollet J
      – PersonEntity:
          Name:
            NameFull: White JA
      – PersonEntity:
          Name:
            NameFull: Keegan B
      – PersonEntity:
          Name:
            NameFull: Versteeg L
      – PersonEntity:
          Name:
            NameFull: Strych U
      – PersonEntity:
          Name:
            NameFull: Chen WH
      – PersonEntity:
          Name:
            NameFull: Mohamath R
      – PersonEntity:
          Name:
            NameFull: Ramer-Denisoff G
      – PersonEntity:
          Name:
            NameFull: Reed S
      – PersonEntity:
          Name:
            NameFull: Renshaw C
      – PersonEntity:
          Name:
            NameFull: Beaver S
      – PersonEntity:
          Name:
            NameFull: Gerhardt A
      – PersonEntity:
          Name:
            NameFull: Voigt EA
      – PersonEntity:
          Name:
            NameFull: Tomai MA
      – PersonEntity:
          Name:
            NameFull: Sitrin R
      – PersonEntity:
          Name:
            NameFull: Choy RKM
      – PersonEntity:
          Name:
            NameFull: Cassels FJ
      – PersonEntity:
          Name:
            NameFull: Hotez PJ
      – PersonEntity:
          Name:
            NameFull: Bottazzi ME
      – PersonEntity:
          Name:
            NameFull: Fox CB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 12
              Text: 2024 Dec 16
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1